Syndivia is committed to enhancing treatment options for cancer patients with solid tumors by leveraging the distinctive properties of targeted DAR1 antibody-drug conjugates, which offer improved tumor penetration, stability, and efficacy.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 8, Allée Gaspard Monge, Strasbourg,grand Est 67083,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- syndivia.com
- HQ
- Strasbourg, Grand Est
Syndivia Questions
Syndivia's website is syndivia.com
Syndivia's LinkedIn profile is https://fr.linkedin.com/company/syndivia
Syndivia has
6 employees.
View email and phone details for 6
employees at Syndivia.
Syndivia's industry is
Biotechnology Research
Syndivia's top competitors are
Salto Therapeutics,
Biosynex Pharma,
Novalix,
Inatherys,
Anagenesis Biotechnologies,
Toda Pharma,
Domain Therapeutics,
Lamina Therapeutics,
Inoviem Scientific,
Elitepharm Laboratoires (Trading Point).
Syndivia's categories are Biotechnology Research
Syndivia's founding year is 2014
